vs

Side-by-side financial comparison of Creative Media & Community Trust Corp (CMCT) and PETMED EXPRESS INC (PETS). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $28.5M, roughly 1.4× Creative Media & Community Trust Corp). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -125.8%, a 99.8% gap on every dollar of revenue. On growth, Creative Media & Community Trust Corp posted the faster year-over-year revenue change (3.6% vs -23.3%). Over the past eight quarters, Creative Media & Community Trust Corp's revenue compounded faster (-8.5% CAGR vs -20.9%).

Creative Media & Community Trust Corp is a U.S.-headquartered real estate investment trust operating two core segments: it owns, manages and develops creative media facilities including professional film and TV production studios, plus community-focused assets such as affordable housing, neighborhood healthcare centers and local commercial spaces, serving media operators and local communities nationwide.

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

CMCT vs PETS — Head-to-Head

Bigger by revenue
PETS
PETS
1.4× larger
PETS
$40.7M
$28.5M
CMCT
Growing faster (revenue YoY)
CMCT
CMCT
+26.9% gap
CMCT
3.6%
-23.3%
PETS
Higher net margin
PETS
PETS
99.8% more per $
PETS
-26.0%
-125.8%
CMCT
Faster 2-yr revenue CAGR
CMCT
CMCT
Annualised
CMCT
-8.5%
-20.9%
PETS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CMCT
CMCT
PETS
PETS
Revenue
$28.5M
$40.7M
Net Profit
$-11.4M
$-10.6M
Gross Margin
23.3%
Operating Margin
-125.6%
-25.7%
Net Margin
-125.8%
-26.0%
Revenue YoY
3.6%
-23.3%
Net Profit YoY
-11.4%
-1392.6%
EPS (diluted)
$-3.89
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CMCT
CMCT
PETS
PETS
Q4 25
$28.5M
$40.7M
Q3 25
$26.2M
$44.4M
Q2 25
$29.7M
$51.2M
Q1 25
$32.3M
$50.8M
Q4 24
$27.5M
$52.0M
Q3 24
$28.6M
$58.0M
Q2 24
$34.4M
$66.2M
Q1 24
$34.0M
$65.1M
Net Profit
CMCT
CMCT
PETS
PETS
Q4 25
$-11.4M
$-10.6M
Q3 25
$-12.5M
$-8.5M
Q2 25
$-9.0M
$-34.2M
Q1 25
$-6.1M
$-11.6M
Q4 24
$-10.3M
$-707.0K
Q3 24
$-10.4M
$2.3M
Q2 24
$-796.0K
$3.8M
Q1 24
$-3.7M
$-5.0M
Gross Margin
CMCT
CMCT
PETS
PETS
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
CMCT
CMCT
PETS
PETS
Q4 25
-125.6%
-25.7%
Q3 25
-47.7%
-18.9%
Q2 25
-30.3%
-66.7%
Q1 25
-19.0%
-11.9%
Q4 24
-128.8%
-0.9%
Q3 24
-36.9%
1.0%
Q2 24
-1.6%
6.6%
Q1 24
-10.7%
-5.9%
Net Margin
CMCT
CMCT
PETS
PETS
Q4 25
-125.8%
-26.0%
Q3 25
-47.5%
-19.2%
Q2 25
-30.3%
-66.7%
Q1 25
-18.9%
-22.9%
Q4 24
-129.8%
-1.4%
Q3 24
-36.3%
4.0%
Q2 24
-2.3%
5.7%
Q1 24
-11.0%
-7.7%
EPS (diluted)
CMCT
CMCT
PETS
PETS
Q4 25
$-3.89
$-0.50
Q3 25
$-23.52
$-0.41
Q2 25
$-18.94
$-1.65
Q1 25
$-20.73
$-0.56
Q4 24
$97.71
$-0.03
Q3 24
$-305.04
$0.11
Q2 24
$-98.64
$0.18
Q1 24
$-125.46
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CMCT
CMCT
PETS
PETS
Cash + ST InvestmentsLiquidity on hand
$15.4M
$26.9M
Total DebtLower is stronger
$509.8M
Stockholders' EquityBook value
$265.4M
$32.8M
Total Assets
$859.2M
$88.0M
Debt / EquityLower = less leverage
1.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CMCT
CMCT
PETS
PETS
Q4 25
$15.4M
$26.9M
Q3 25
$17.3M
$36.1M
Q2 25
$27.8M
$41.1M
Q1 25
$19.8M
$54.7M
Q4 24
$20.3M
$50.1M
Q3 24
$18.5M
$52.0M
Q2 24
$29.3M
$46.0M
Q1 24
$21.3M
$55.3M
Total Debt
CMCT
CMCT
PETS
PETS
Q4 25
$509.8M
Q3 25
$527.8M
Q2 25
$535.6M
Q1 25
$512.7M
Q4 24
$505.7M
Q3 24
$478.3M
Q2 24
$485.1M
Q1 24
$472.8M
Stockholders' Equity
CMCT
CMCT
PETS
PETS
Q4 25
$265.4M
$32.8M
Q3 25
$281.9M
$43.1M
Q2 25
$287.1M
$51.5M
Q1 25
$293.0M
$85.1M
Q4 24
$304.5M
$96.2M
Q3 24
$321.0M
$96.4M
Q2 24
$351.1M
$93.5M
Q1 24
$369.9M
$96.7M
Total Assets
CMCT
CMCT
PETS
PETS
Q4 25
$859.2M
$88.0M
Q3 25
$871.8M
$100.3M
Q2 25
$885.0M
$109.8M
Q1 25
$882.3M
$148.7M
Q4 24
$889.6M
$144.8M
Q3 24
$868.0M
$146.0M
Q2 24
$891.2M
$152.7M
Q1 24
$887.5M
$169.9M
Debt / Equity
CMCT
CMCT
PETS
PETS
Q4 25
1.92×
Q3 25
1.87×
Q2 25
1.87×
Q1 25
1.75×
Q4 24
1.66×
Q3 24
1.49×
Q2 24
1.38×
Q1 24
1.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CMCT
CMCT
PETS
PETS
Operating Cash FlowLast quarter
$5.8M
$-9.2M
Free Cash FlowOCF − Capex
$-9.2M
FCF MarginFCF / Revenue
-22.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CMCT
CMCT
PETS
PETS
Q4 25
$5.8M
$-9.2M
Q3 25
$3.7M
$-2.2M
Q2 25
$-2.5M
$-12.3M
Q1 25
$1.2M
$7.0M
Q4 24
$17.0M
$-1.2M
Q3 24
$10.3M
$7.4M
Q2 24
$3.9M
$-8.5M
Q1 24
$1.6M
$7.1M
Free Cash Flow
CMCT
CMCT
PETS
PETS
Q4 25
$-9.2M
Q3 25
$-4.8M
Q2 25
$-13.6M
Q1 25
$4.6M
Q4 24
$-1.9M
Q3 24
$6.1M
Q2 24
$-9.2M
Q1 24
$5.9M
FCF Margin
CMCT
CMCT
PETS
PETS
Q4 25
-22.7%
Q3 25
-10.8%
Q2 25
-26.5%
Q1 25
9.1%
Q4 24
-3.7%
Q3 24
10.6%
Q2 24
-13.9%
Q1 24
9.0%
Capex Intensity
CMCT
CMCT
PETS
PETS
Q4 25
0.1%
Q3 25
5.9%
Q2 25
2.5%
Q1 25
4.7%
Q4 24
1.5%
Q3 24
2.2%
Q2 24
1.0%
Q1 24
1.9%
Cash Conversion
CMCT
CMCT
PETS
PETS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CMCT
CMCT

Segment breakdown not available.

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

Related Comparisons